PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (PMVP)

Q: What does CUSIP 69353Y103 represent in this 13F holders report?

CUSIP 69353Y103 is the security identifier for PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share used to aggregate holder disclosures.

Q: How many institutions held PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share in Q3 2026?

1 institutional investor reported PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share for Q3 2026. Use the holders table for investor-level position and value details.

CUSIP: 69353Y103

Q3 2026 13F Holders as of 30 Sep 2026

Security type / class: Equity / Common Stock, $0.00001 par value per share
Total 13F shares: 328,744
Total 13F value: $549,002
Share change: -1,259
SEC-reported price per share: $1.67
Number of holders: 1
Value change: -$2,103
Number of sells: 1
Shares outstanding: 76,540,071

Security key

69353Y103

Report period

Q3 2026

Institutions

Top holders

PMVP full security history Ownership snapshot Full 13F holder table Previous quarter: Q3 2025 PMV Pharmaceuticals, Inc. SEC filings PMV Pharmaceuticals, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 69353Y103

Previous quarter: Q3 2025

Recent filing periods:

Q3 2026 Q3 2025

Ownership snapshot

Top reported holders of PMVP - PMV Pharmaceuticals, Inc. - Common Stock, $0.00001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Samsara BioCapital, L.P.

Disclosed value leader

Samsara BioCapital, L.P.

Comparable rows

15/15

Latest evidence

02 Sep 2026

13D/G 13F 3/4/5 Lead comparable stake: 9.9% 13D/G row: Samsara BioCapital, L.P. Showing 1-6 of 15 holder rows.

Quick read

Samsara BioCapital, L.P. leads the comparable SEC ownership view at 9.9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Samsara BioCapital, L.P.'s linked filing trail.

Comparable ownership Top 5

Samsara BioCapital, L.P. 9.9%

BML Investment Partners, L.P. 9.9%

TANG CAPITAL MANAGEMENT LLC 8.9%

Sio Capital Management, LLC 4.9%

Euclidean Capital LLC 4.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Samsara BioCapital, L.P.	13D/G Srinivas Akkaraju 13D/G	9.9%	$9,547,608 7,577,467 shares	$0	02 Sep 2026
BML Investment Partners, L.P.	13D/G 13D/G	9.9%	$6,615,000 5,292,000 shares	+$2,527,616	31 Dec 2025
TANG CAPITAL MANAGEMENT LLC	13D/G 13F Company 13D/G 13F	8.9%	$6,702,907 4,720,357 shares	$0	16 Sep 2025
Sio Capital Management, LLC	13F 13D/G Company 13F 13D/G	4.9% from 13D/G	$3,529,744 2,634,137 shares	—	30 Jun 2026
Euclidean Capital LLC	13F 13D/G 3/4/5 Company · 10%+ Owner 13F 13D/G 3/4/5	4.9% from 13D/G	$3,521,042 2,627,643 shares	—	30 Jun 2026
ArrowMark Colorado Holdings LLC	13F 13D/G Company 13F 13D/G	3.7% from 13D/G	$2,625,836 1,959,579 shares	—	30 Jun 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

328,744

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2026 vs Q3 2025 Across Filers

Q3 2025 holders

Q3 2026 holders

Holder diff

-62

Investor	Q3 2025 Shares	Q3 2026 Shares	Share Diff	Share Chg %	Q3 2025 value	Q3 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend